FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

37411004: Tissue plasminogen activator (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
62404015 Tissue plasminogen activator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
62405019 T-PA en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
769275011 Tissue plasminogen activator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tissue plasminogen activator Is a Plasminogen activator false Inferred relationship Some
Tissue plasminogen activator Is a Hydrolase false Inferred relationship Some
Tissue plasminogen activator This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hydrolase (disposition) false Inferred relationship Some
Tissue plasminogen activator This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Plasminogen activator (disposition) true Inferred relationship Some
Tissue plasminogen activator Is a Enzyme activator true Inferred relationship Some
Tissue plasminogen activator Is a Substance with protease mechanism of action false Inferred relationship Some
Tissue plasminogen activator Is a Protein true Inferred relationship Some
Tissue plasminogen activator Is a Peptide hydrolase true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
tPA-PAI complex assay Has measured component (attribute) False Tissue plasminogen activator Inferred relationship Some
Tissue plasminogen activator assay Has measured component (attribute) False Tissue plasminogen activator Inferred relationship Some
Tissue plasminogen activator activity assay Has measured component (attribute) False Tissue plasminogen activator Inferred relationship Some
Tissue plasminogen activator antigen assay Has measured component (attribute) False Tissue plasminogen activator Inferred relationship Some
Tissue plasminogen activator antigen Direct substance False Tissue plasminogen activator Inferred relationship Some
tPA-PAI complex assay Component False Tissue plasminogen activator Inferred relationship Some 2
Tissue plasminogen activator assay Component True Tissue plasminogen activator Inferred relationship Some 1
Tissue plasminogen activator activity assay Component True Tissue plasminogen activator Inferred relationship Some 1
Tissue plasminogen activator antigen assay Component True Tissue plasminogen activator Inferred relationship Some 1
Reteplase (substance) Is a False Tissue plasminogen activator Inferred relationship Some
Alteplase (substance) Is a False Tissue plasminogen activator Inferred relationship Some
Tenecteplase (substance) Is a False Tissue plasminogen activator Inferred relationship Some
Product containing tissue plasminogen activator (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tissue plasminogen activator Inferred relationship Some 1
Product containing reteplase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Alteplase 50mg powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Alteplase 20mg powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Alteplase 10mg powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Reteplase 10units powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Product containing tenecteplase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Product containing alteplase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Tenecteplase 8000iu(40mg) powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Tenecteplase 10,000iu(50mg) inj (pdr for recon)+solvent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Alteplase 1mg injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Reteplase, recombinant 10unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Alteplase 100mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tissue plasminogen activator Inferred relationship Some
Product containing only tissue plasminogen activator (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tissue plasminogen activator Inferred relationship Some 1
Fibrinolytic disorder caused by tissue plasminogen activator Causative agent (attribute) True Tissue plasminogen activator Inferred relationship Some 2
Intravenous injection of tissue plasminogen activator (procedure) Direct substance True Tissue plasminogen activator Inferred relationship Some 1
Intra-arterial injection of tissue plasminogen activator Direct substance True Tissue plasminogen activator Inferred relationship Some 1
Adverse reaction caused by tissue plasminogen activator (disorder) Causative agent (attribute) True Tissue plasminogen activator Inferred relationship Some 1
tPA-PAI complex assay Component True Tissue plasminogen activator Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start